[Bactrim Roche, a combination preparation of sulfamethoxazole and trimethoprim].
D003875:Drug Eruptions / Q000209:etiology; D004357:Drug Synergism; D004751:Enteritis / Q000188:drug therapy; D004926:Escherichia coli / Q000187:drug effects; D005493:Folic Acid Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D007970:Leukopenia / Q000139:chemically induced; D009325:Nausea / Q000139:chemically induced; D011511:Proteus / Q000187:drug effects; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced; D014552:Urinary Tract Infections / Q000188:drug therapy*
D005493:Folic Acid Antagonists; D011743:Pyrimidines; D013420:Sulfamethoxazole
Bactrim Roche, ein Kombinationspräparat von Sulfamethoxazol und Trimethoprim.